|Dr. Robert Brookins B.A., B.Sc., Ph.D.||CEO, MD & Director||208.12k||N/A||N/A|
|Mr. Jason Lewis||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Mark Wise||VP of Investor Relations & Corp. Communications||N/A||N/A||N/A|
|Ms. Maja McGuire||Company Sec. & Gen. Counsel||N/A||N/A||N/A|
|Mr. Scott Hunter||VP of Sales||N/A||N/A||N/A|
Alexium International Group Limited develops and sells specialty chemicals and solutions in Australia and the United States. The company offers flame retardant (FR) treatments, including Alexiflam FR for use in synthetic and synthetic-blend fabrics; Alexiflam NF for use in cotton and cotton-blends; and Alexicool, a chemical finish for fabrics. In addition, the company offers FR NyCo technology, a measure for flame retardant protection in military uniforms. Its products are used in defense applications; and consumer applications, such as automotive and transportation, outdoor fabrics, and bedding and decorative fabrics. The company is headquartered in Perth, Australia.
Alexium International Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.